Exhaled NO Testing in Filariasis
Tracking Information | |||||
---|---|---|---|---|---|
First Received Date ICMJE | June 22, 2012 | ||||
Last Updated Date | June 22, 2012 | ||||
Start Date ICMJE | May 2012 | ||||
Estimated Primary Completion Date | September 2012 (final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures ICMJE | |||||
Original Primary Outcome Measures ICMJE | |||||
Change History | No Changes Posted | ||||
Current Secondary Outcome Measures ICMJE | |||||
Original Secondary Outcome Measures ICMJE | |||||
Current Other Outcome Measures ICMJE | |||||
Original Other Outcome Measures ICMJE | |||||
Descriptive Information | |||||
Brief Title ICMJE | Exhaled NO Testing in Filariasis | ||||
Official Title ICMJE | Exhaled NO Testing in Filariasis | ||||
Brief Summary | This study is looking at the difference in exhaled nitric oxide levels in patients with and without laboratory evidence of filariasis. |
||||
Detailed Description | |||||
Study Type ICMJE | Observational | ||||
Study Design ICMJE | Time Perspective: Cross-Sectional | ||||
Biospecimen | |||||
Sampling Method | Non-Probability Sample | ||||
Study Population | Study subjects:
Control subjects: Controls will be matched with cases by gender, age and region of residence. They will have non-emergent complaints without respiratory symptoms. |
||||
Condition ICMJE | Filariasis | ||||
Intervention ICMJE | |||||
Study Group/Cohort (s) |
|
||||
Publications * | |||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status ICMJE | Recruiting | ||||
Estimated Enrollment ICMJE | 180 | ||||
Estimated Completion Date | September 2012 | ||||
Estimated Primary Completion Date | September 2012 (final data collection date for primary outcome measure) | ||||
Eligibility Criteria ICMJE | Inclusion Criteria:
1. Wheezing 2. Shortness of breath 3. Chest tightness 4. Cough ii. Disposition to the asthma room after triage and physician evaluation (disposition to other areas of the A&E allowed if due to no available space in the asthma room) iii. Patients are potentially eligible with or without a past history of health care provider diagnosed asthma iv. Patients are potentially eligible regardless of the number of previous episodes of wheezing (i.e. patients with a first episode of bronchospasm are potentially eligible) v. If suspected or documented to have pneumonia or a pulmonary infiltrate, patients are potentially eligible if:
1. Have purulent sputum production 2. Have known or suspected: a. Tuberculosis b. Immunodeficiency c. Congestive heart failure d. Foreign body aspiration b. Patients presenting with a chief complaint of cough: i. Potentially eligible patients will have a cough of greater than one week (seven days) duration ii. Asthma room disposition is not required for these subjects iii. If suspected or documented to have pneumonia or a pulmonary infiltrate, patients are potentially eligible if: 1. They have a dry cough (no production of purulent sputum) iv. Patients with cough are not eligible if:
Exclusion Criteria:
|
||||
Gender | Both | ||||
Ages | 6 Years and older | ||||
Accepts Healthy Volunteers | Yes | ||||
Contacts ICMJE |
|
||||
Location Countries ICMJE | Guyana | ||||
Administrative Information | |||||
NCT Number ICMJE | NCT01628497 | ||||
Other Study ID Numbers ICMJE | Fil-01 | ||||
Has Data Monitoring Committee | No | ||||
Responsible Party | Seth Wright, Vanderbilt University | ||||
Study Sponsor ICMJE | Vanderbilt University | ||||
Collaborators ICMJE | |||||
Investigators ICMJE | |||||
Information Provided By | Vanderbilt University | ||||
Verification Date | June 2012 | ||||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |